Investigating how specific microRNAs affect retinal cell development and reprogramming.

The Role of Retinal Progenitor microRNAs for Late-stage Progenitor Cell State and Muller Glia Reprogramming

NIH-funded research State College of Optometry · NIH-11046603

This study is looking at tiny molecules called microRNAs to see how they help retinal cells grow and work properly, which could lead to new ways to treat vision loss from eye disorders.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState College of Optometry NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11046603 on NIH RePORTER

What this research studies

This research focuses on understanding the role of microRNAs in the development and function of retinal cells, particularly in preventing blindness caused by retinal disorders. The team will identify specific microRNAs that are crucial for the proper formation of retinal cells during early postnatal development. They will also explore the potential of these microRNAs to reprogram Müller glia cells into functional retinal neurons, which could lead to innovative therapies for vision restoration. By using a specialized mouse model, the researchers aim to uncover how the absence of these microRNAs affects retinal cell behavior and development.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing age-related macular degeneration or other retinal disorders.

Not a fit: Patients with retinal conditions unrelated to microRNA dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that restore vision in patients suffering from retinal diseases.

How similar studies have performed: Previous research has shown promise in using microRNAs for cellular reprogramming, indicating that this approach could be effective.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age related macular disease
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.